Lavelle Ed C, O'Hagan D T
Adjuvant Research Group, School of Biochemistry and Immunology, Trinity College, Dublin 2, Ireland.
Expert Opin Drug Deliv. 2006 Nov;3(6):747-62. doi: 10.1517/17425247.3.6.747.
The oral route is the ideal means of delivering prophylactic and therapeutic vaccines, offering significant advantages over systemic delivery. Most notably, oral delivery is associated with simple administration and improved safety. In addition, unlike systemic immunisation, oral delivery can induce mucosal immune responses. However, the oral route of vaccine delivery is the most difficult because of the numerous barriers posed by the gastrointestinal tract. To facilitate effective immunisation with peptide and protein vaccines, antigens must be protected, uptake enhanced and the innate immune response activated. Numerous delivery systems and adjuvants have been evaluated for oral vaccine delivery, including live vectors, inert particles and bacterial toxins. Although developments in oral vaccines have been disappointing so far, in terms of the generation of products, the availability of a range of novel delivery systems offers much greater hope for the future development of improved oral vaccines.
口服途径是递送预防性和治疗性疫苗的理想方式,与全身给药相比具有显著优势。最值得注意的是,口服给药具有给药简便和安全性提高的特点。此外,与全身免疫不同,口服给药可诱导黏膜免疫反应。然而,由于胃肠道存在众多屏障,疫苗的口服递送途径是最困难的。为促进肽和蛋白质疫苗的有效免疫,必须保护抗原、增强摄取并激活先天免疫反应。已对多种用于口服疫苗递送的递送系统和佐剂进行了评估,包括活载体、惰性颗粒和细菌毒素。尽管到目前为止口服疫苗的研发成果令人失望,但就产品的产生而言,一系列新型递送系统的出现为改进口服疫苗的未来发展带来了更大希望。